Moderna, Merck cancer vaccine data 'a great result, but not entirely unexpected', says Simon Baker

Simon Baker, Rothschild & Co Redburn global biopharma research co-head, joins 'Squawk on the Street' to discuss Moderna and ...

Moderna's cancer vaccine hits key goal in melanoma trial with NYU Langone link

Moderna shares jumped this week after the company announced encouraging results from a late-stage melanoma trial.

Cleveland team develops cancer vaccine using COVID immunity

University Hospitals and Celloram are advancing Protexi, a platform that redirects antiviral immune memory from COVID-19 ...
C&EN

In a first, an mRNA cancer vaccine succeeds in late-stage clinical trial

Moderna’s vaccine, intismeran, is a personalized neoantigen vaccine. It delivers mRNA that encodes tumor-specific mutations ...

Skin cancer vaccine slashes risk of dying from the disease - giving hope to thousands

Scientists have hailed the development of the melanoma jab as a 'pivotal moment' in the fight against the deadly disease - ...

Evaxion expands and refocuses R&D pipeline with EVX-05, an AI-designed off-the-shelf brain cancer vaccine program

EVX-05 is an off-the-shelf therapeutic glioblastoma (brain cancer) vaccine designed based on patient tumor samples. It targets novel conserved antigens identified using Evaxion’s AI-Immunology™ ...